On June 6, 2017, Kite Pharma, Inc., (NASDAQ:$KITE), which is a prominent cell therapy company headquartered in Santa Monica, announced that they will be presenting at two investor conferences in June 2017.
The conferences are as followed:
- Jefferies 2017 Global Healthcare Conference – Wednesday, June 7, 1:30 pm ET, New York, NY.
- Goldman Sachs 38th Annual Global Healthcare Conference – Tuesday, June 13, 2:00 PT, Rancho Palos Verdes, CA
For those that are unable to attend the conference but still want to learn more about investing in biotech stocks, you can access a live audio webcast of each conference on the Investors section of Kite’s website, www.kitepharma.com. For roughly 30 days there will be a replay of each webcast available on the website stated above.
A Brief Overview: Kite Pharma, Inc.
As mentioned, Kite Pharma is a prominent biopharmaceutical company involved in the development of innovative cancer immunotherapies. The company’s goal is to provide a rapid, long-term reliable response and eliminate the issues seen with chronic care. Kite focuses on chimeric antigen receptor (CAR) and T cell receptor (TCR) engineered cell therapies which are designed to enable the immune system’s capacity to recognize and terminate tumors.
For more information, visit www.kitepharma.com or sign up to follow Kite Pharma, Inc. on twitter.
Featured Image: kitepharma.com
